ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Plans Grants For Those Who Barely Miss Payline

April 19, 1991

Senate, House Budget Plans Likely To Result In Modest Funding Increases For NIH, NCI

May 11, 1990

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program

September 23, 1983

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996

The Number of Adult Cooperative Groups Drops to Four As NSABP, RTOG And GOG Agree to Merge

October 21, 2011